HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32210451.
- Also identified by DOI 10.1371/journal.pone.0230450 and PMC identifier 7094838.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hepatocellular carcinoma (HCC) is one of the most common human cancers, its prevalence and severity need us to discover novel early diagnostic biomarkers and new therapeutic strategies. MicroRNA-122 is the most abundant microRNA in the liver, and acts as a tumor suppressor and represses HCC development. In our study we showed that HNF-4α and MiR-122 were down-regulated significantly in hepatocellular carcinoma. Over-expression of HNF-4α inhibit hepatocellular carcinoma cells proliferation. And miR-122 is one of the downstream effector of HNF-4α. Up-regulated miR-122 inhibited hepatocellular carcinoma cells proliferation through regulating ADAM17. Collectively, our results suggested that HNF-4α could inhibit hepatocellular carcinoma proliferation with miR-122 being a downstream target of it. And miR-122 would inhibit hepatocellular carcinoma proliferation by regulating ADAM17 signal pathway.
Medical subject headings
- ADAM17 Protein
- Carcinoma, Hepatocellular
- Hepatocyte Nuclear Factor 4
- Liver Neoplasms
- MicroRNAs